Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Steroid 12 shows promise as a targeted treatment for prostate cancer by selectively reducing cell growth and increasing cell death.

The MEST method increases cell yield and volume for regenerative medicine but needs more testing.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Finasteride is stable except in high pH, and lactose and magnesium stearate should be replaced in formulations.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Blocking progesterone metabolism can cause depression-like behavior in mice.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

Provenge extends prostate cancer survival by about 4 months.

The new microneedle system safely delivers finasteride through the skin to treat hair loss.

The new gel formulation effectively delivers Finasteride for hair growth treatment without skin irritation.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.